J
Jose Dizon
Researcher at Columbia University
Publications - 81
Citations - 2751
Jose Dizon is an academic researcher from Columbia University. The author has contributed to research in topics: Atrial fibrillation & Percutaneous coronary intervention. The author has an hindex of 23, co-authored 76 publications receiving 2318 citations. Previous affiliations of Jose Dizon include Emory University & Columbia University Medical Center.
Papers
More filters
Journal ArticleDOI
Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial.
Gregg W. Stone,Akiko Maehara,Bernhard Witzenbichler,Jacek Godlewski,Helen Parise,Jan-Henk E. Dambrink,Andrzej Ochała,Trevor Carlton,Ecaterina Cristea,Steven D. Wolff,Sorin J. Brener,Saqib Chowdhary,Magdi El-Omar,Thomas Neunteufl,D. Christopher Metzger,Theodore Karwoski,Jose Dizon,Roxana Mehran,C. Michael Gibson +18 more
TL;DR: To determine whether bolus intracoronary abciximab, manual aspiration thrombectomy, or both reduce infarct size in high-risk patients with STEMI, an open-label, 2 x 2 factorial design was conducted.
Journal ArticleDOI
Predictors and Clinical Outcomes of Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement: The PARTNER (Placement of AoRtic TraNscathetER Valves) Trial and Registry
Tamim Nazif,Jose Dizon,Rebecca T. Hahn,Ke Xu,Vasilis Babaliaros,Pamela S. Douglas,Mikhael F. El-Chami,Howard C. Herrmann,Michael J. Mack,Raj Makkar,D. Craig Miller,Augusto D. Pichard,E. Murat Tuzcu,Wilson Y. Szeto,John G. Webb,Jeffrey W. Moses,Craig R. Smith,Mathew R. Williams,Martin B. Leon,Susheel Kodali,Partner Publications Office +20 more
TL;DR: New PPM was associated with a longer duration of hospitalization and higher rates of repeatospitalization and mortality or repeat hospitalization at 1 year, and the prosthesis to LV outflow tract diameter ratio and the LV end-diastolic diameter were identified as novel predictors of PPM after TAVR.
Journal ArticleDOI
Effects of Left Ventricular Assist Device Therapy on Ventricular Arrhythmias
TL;DR: After LVAD placement, there is a significant rise in the incidence of de novo MVT, and serum electrolyte abnormality was an independent predictor of post-LVAD ventricular arrhythmias.
Journal ArticleDOI
Clinical implications of new-onset left bundle branch block after transcatheter aortic valve replacement: analysis of the PARTNER experience.
Tamim Nazif,Mathew R. Williams,Rebecca T. Hahn,Samir R. Kapadia,Vasilis Babaliaros,Josep Rodes-Cabau,Wilson Y. Szeto,Hasan Jilaihawi,William F. Fearon,Danny Dvir,Todd M. Dewey,Raj Makkar,Ke Xu,Jose Dizon,Craig R. Smith,Martin B. Leon,Susheel Kodali +16 more
TL;DR: Persistent, new-onset LBBB was not associated with death, repeat hospitalization, stroke, or myocardial infarction at 1 year, but was associated with a higher rate of PPI and failure of left ventricular ejection fraction to improve.
Journal ArticleDOI
Prospective, Randomized, Multicenter Evaluation of a Polyethylene Terephthalate Micronet Mesh–Covered Stent (MGuard) in ST-Segment Elevation Myocardial Infarction: The MASTER Trial
Gregg W. Stone,Alexandre Abizaid,Sigmund Silber,Jose Dizon,Béla Merkely,Ricardo A. Costa,Ran Kornowski,Andrea Abizaid,Roman Wojdyla,Akiko Maehara,Ovidiu Dressler,Sorin J. Brener,Eli Bar,Dariusz Dudek +13 more
TL;DR: Among patients with acute STEMI undergoing emergent PCI, the MGuard micronet mesh-covered stent compared with conventional metal stents resulted in superior rates of epicardial coronary flow and complete ST-segment resolution.